132 related articles for article (PubMed ID: 9895048)
1. Influence of the 'directions for use' on positivity rates of the Hemoccult II test.
Faure H; Exbrayat C; Garnier A; Dumas P; Winckel P; Bolla M
Eur J Gastroenterol Hepatol; 1998 Dec; 10(12):1021-4. PubMed ID: 9895048
[TBL] [Abstract][Full Text] [Related]
2. Moisture content of Hemoccult slides influences test sensitivity.
Faure H; Exbrayat C; Winckel P; Bolla M
Eur J Gastroenterol Hepatol; 2003 Oct; 15(10):1111-4. PubMed ID: 14501620
[TBL] [Abstract][Full Text] [Related]
3. A comparison of fecal occult-blood tests for colorectal-cancer screening.
Allison JE; Tekawa IS; Ransom LJ; Adrain AL
N Engl J Med; 1996 Jan; 334(3):155-9. PubMed ID: 8531970
[TBL] [Abstract][Full Text] [Related]
4. Performance characteristics and comparison of two immunochemical and two guaiac fecal occult blood screening tests for colorectal neoplasia.
Rozen P; Knaani J; Samuel Z
Dig Dis Sci; 1997 Oct; 42(10):2064-71. PubMed ID: 9365136
[TBL] [Abstract][Full Text] [Related]
5. Hemoccult screening in detecting colorectal neoplasm: sensitivity, specificity, and predictive value. Long-term follow-up in a large group practice setting.
Allison JE; Feldman R; Tekawa IS
Ann Intern Med; 1990 Mar; 112(5):328-33. PubMed ID: 2407166
[TBL] [Abstract][Full Text] [Related]
6. Immunochemical vs guaiac faecal occult blood tests in a population-based screening programme for colorectal cancer.
Castiglione G; Zappa M; Grazzini G; Mazzotta A; Biagini M; Salvadori P; Ciatto S
Br J Cancer; 1996 Jul; 74(1):141-4. PubMed ID: 8679448
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the specificity and sensitivity of Hemoccult and HemoQuant in screening for colorectal neoplasia.
St John DJ; Young GP; McHutchison JG; Deacon MC; Alexeyeff MA
Ann Intern Med; 1992 Sep; 117(5):376-82. PubMed ID: 1503328
[TBL] [Abstract][Full Text] [Related]
8. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population.
Imperiale TF; Ransohoff DF; Itzkowitz SH; Turnbull BA; Ross ME;
N Engl J Med; 2004 Dec; 351(26):2704-14. PubMed ID: 15616205
[TBL] [Abstract][Full Text] [Related]
9. Stool DNA and occult blood testing for screen detection of colorectal neoplasia.
Ahlquist DA; Sargent DJ; Loprinzi CL; Levin TR; Rex DK; Ahnen DJ; Knigge K; Lance MP; Burgart LJ; Hamilton SR; Allison JE; Lawson MJ; Devens ME; Harrington JJ; Hillman SL
Ann Intern Med; 2008 Oct; 149(7):441-50, W81. PubMed ID: 18838724
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of new occult blood tests for detection of colorectal neoplasia.
St John DJ; Young GP; Alexeyeff MA; Deacon MC; Cuthbertson AM; Macrae FA; Penfold JC
Gastroenterology; 1993 Jun; 104(6):1661-8. PubMed ID: 8500724
[TBL] [Abstract][Full Text] [Related]
11. A population-based comparison of immunochemical fecal occult blood tests for colorectal cancer screening.
Raginel T; Puvinel J; Ferrand O; Bouvier V; Levillain R; Ruiz A; Lantieri O; Launoy G; Guittet L
Gastroenterology; 2013 May; 144(5):918-25. PubMed ID: 23376426
[TBL] [Abstract][Full Text] [Related]
12. Excellent performance of Hemoccult Sensa in organised colorectal cancer screening.
Kershenbaum A; Flugelman A; Lejbkowicz F; Arad H; Rennert G
Eur J Cancer; 2013 Mar; 49(4):923-30. PubMed ID: 23099005
[TBL] [Abstract][Full Text] [Related]
13. Positivity rates and performances of immunochemical faecal occult blood tests at different cut-off levels within a colorectal cancer screening programme.
Faivre J; Dancourt V; Manfredi S; Denis B; Durand G; Gendre I; Bidan JM; Jard C; Levillain R; Jung S; Viguier J; Dorval E
Dig Liver Dis; 2012 Aug; 44(8):700-4. PubMed ID: 22542582
[TBL] [Abstract][Full Text] [Related]
14. Patterns of occult bleeding in asymptomatic colorectal cancer.
Ahlquist DA; McGill DB; Fleming JL; Schwartz S; Wieand HS; Rubin J; Moertel CG
Cancer; 1989 May; 63(9):1826-30. PubMed ID: 2702590
[TBL] [Abstract][Full Text] [Related]
15. Screening of first degree relatives of patients operated for colorectal cancer: evaluation of fecal calprotectin vs. hemoccult II.
Kristinsson J; Nygaard K; Aadland E; Barstad S; Sauar J; Hofstad B; Stray N; Stallemo A; Haug B; Ugstad M; Tøn H; Fuglerud P
Digestion; 2001; 64(2):104-10. PubMed ID: 11684824
[TBL] [Abstract][Full Text] [Related]
16. Interval cancers in screening with fecal occult blood test for colorectal cancer.
Jensen BM; Kronborg O; Fenger C
Scand J Gastroenterol; 1992 Sep; 27(9):779-82. PubMed ID: 1411286
[TBL] [Abstract][Full Text] [Related]
17. Screening for colorectal cancer. A comparison of 3 fecal occult blood tests.
Levin B; Hess K; Johnson C
Arch Intern Med; 1997 May; 157(9):970-6. PubMed ID: 9140267
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity of the Hemoccult II slide test in detecting colonic neoplasms.
Poleski MH; Gordon PH
Can J Surg; 1986 Mar; 29(2):99-101. PubMed ID: 3955472
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic yield of a one sample immunochemical test at different cut-off values in an organised screening programme for colorectal cancer.
Hamza S; Dancourt V; Lejeune C; Bidan JM; Lepage C; Faivre J
Eur J Cancer; 2013 Aug; 49(12):2727-33. PubMed ID: 23601670
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
